In the current trading session, Sonoma Pharmaceuticals Inc.’s (SNOA) stock is trading at the price of $2.45, a gain of 104.16% over last night’s close. So, the stock is trading at a price that is -42.36% less than its 52-week high of $4.25 and 144.99% better than its 52-week low of $1.00. Based on the past 30-day period, the stock price is -5.22% below the high and +118.00% above the low.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, SNOA’s SMA-200 is $2.5053.
It is also essential to consider SNOA stock ratios like the price-to-sales ratio, which is 0.29 for the last year.SNOA’s price to book ratio for the most recent quarter was 0.53, resulting in an 1.06 price to cash per share for the period.
How does Sonoma Pharmaceuticals Inc. (SNOA) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a No Ratings. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) Ownership Details
I will give a breakdown of the key shareholders in Sonoma Pharmaceuticals Inc. (SNOA). Recent figures show that the company’s insiders hold 0.39% of shares. A total of 16 institutional investors hold shares in the company, making 5.76% of its stock and 5.78% of its float.
Sep 29, 2022, it was reported that the Company’s largest institutional holder is Renaissance Technologies, LLC holding total of 75367.0 shares that make 2.43% of the company’s total number of shares and are currently priced at 0.16 million.
The securities firm Geode Capital Management, LLC holds 36878.0 shares of SNOA, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 1.19%, and the holding percentage of shares is valued at 77443.0.
An overview of Sonoma Pharmaceuticals Inc.’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Sonoma Pharmaceuticals Inc. (SNOA) traded 2,354,489 shares per day, with a moving average of $1.2275 and price change of +1.03. With the moving average of $1.4693 and a price change of +0.24, about 958,732 shares changed hands on average over the past 50 days. Finally, SNOA’s 100-day average volume is 937,939 shares, alongside a moving average of $1.8740 and a price change of -0.60.
